Mostrar el registro sencillo del ítem

dc.contributor.authorMartín-Vivar, María
dc.contributor.authorVillena, Alejandro
dc.contributor.authorMestre-Bach, Gemma
dc.contributor.authorHurtado-Murillo, Felipe
dc.contributor.authorChiclana Actis, Carlos
dc.date2022
dc.date.accessioned2023-01-19T15:03:11Z
dc.date.available2023-01-19T15:03:11Z
dc.identifier.issn17436095
dc.identifier.urihttps://reunir.unir.net/handle/123456789/14028
dc.description.abstractBackground: Persistent genital arousal disorder (PGAD) is characterized by elevated discomfort associated with persistent genital arousal in the absence of sexual desire. Aim: To perform a scoping review of the proposed treatments for PGAD and their efficacy. Methods: A scoping review was carried out (PRISMA-Scr) that included articles on PGAD as the main disorder, only in women, which explained, in detail, the treatment and its efficacy, was empirical, was written in English and Spanish. No prior filtering by years was performed. Outcomes: Three different effective treatments were found (Physical therapies, pharmacological therapies, and psychotherapeutics in combination with other therapies). Results: Thirty-eight articles were selected. From physical therapies, treatments using neuromodulation, transcutaneous electrical stimulation, Botox, surgery, electroconvulsive therapy, manual therapy, pelvic floor therapy, dietary changes, and transcranial magnetic stimulation showed effectiveness. Using the pharmacological approach, paroxetine, duloxetine, pramipexole, ropinirole, and clonazepam treatments were effective. Psychotherapy treatments showed effectiveness only in combination with other types of treatments, specifically a combination of cognitive–behavioral strategies with pharmacological treatment. Clinical implications: Pharmacological treatment, specifically SSRIs, have proven to be the therapy of choice for different subtypes of patients. Strengths and limitations: This study analyzed treatment effectiveness with different approaches and took into consideration those articles where psychotherapy was used as a combination treatment with pharmacological and physical therapy. The main limitation is that it was focused exclusively on women, and the results cannot be generalized to include men. Conclusions: To date, a combination of pharmacological interventions with physical therapy and, in some occasions, with psychological therapy is main strategy followed to accomplish effective treatment of PGAD. Martín-Vivar M, Villena-Moya A, Mestre-Bach G, et al. Treatments for Persistent Genital Arousal Disorder in Women: A Scoping Review. J Sex Med 2022;19:961–974.es_ES
dc.language.isoenges_ES
dc.publisherJournal of Sexual Medicinees_ES
dc.relation.ispartofseries;vol. 19, nº 6
dc.relation.urihttps://academic.oup.com/jsm/article/19/6/961/6961330es_ES
dc.rightsopenAccesses_ES
dc.subjectfemale sexual dysfunctiones_ES
dc.subjectpersistent genital arousal disorderes_ES
dc.subjectpersistent sexual arousal syndromees_ES
dc.subjectsexual arousal disorderses_ES
dc.subjectScopuses_ES
dc.titleTreatments for Persistent Genital Arousal Disorder in Women: A Scoping Reviewes_ES
dc.typeArticulo Revista Indexadaes_ES
reunir.tag~ARIes_ES
dc.identifier.doihttps://doi.org/10.1016/j.jsxm.2022.03.220


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem